CANO

Emergence from Chapter 11 Expected in Third Quarter of 2024 MIAMI, May 21, 2024 /PRNewswire/ -- Cano Health, Inc. (NYSE: CANO) ("Cano Health" or the "Company"), a leading value-based primary care provider and population health company, today announced a global agreement with the Unsecured Creditors Committee representing the interests of the Company's general unsecured creditors, with the support of the Ad Hoc Lender Group. It also received approval of its Disclosure Statement by the U.S. Bankruptcy Court for the District of Delaware (the "Court"), paving the way to solicit creditor approval of its Plan of Reorganization and its expected emergence from Chapter 11 in the third quarter. Mark

SC 13G/A - Cano Health, Inc. (0001800682) (Subject)

8-K - Cano Health, Inc. (0001800682) (Filer)

SC 13D/A - Cano Health, Inc. (0001800682) (Subject)

8-K - Cano Health, Inc. (0001800682) (Filer)

25-NSE - Cano Health, Inc. (0001800682) (Subject)

8-K - Cano Health, Inc. (0001800682) (Filer)

MIAMI, Feb. 5, 2024 /PRNewswire/ -- Cano Health, Inc. (NYSE:CANO) ("Cano Health" or the "Company") announced today that on February 5, 2024, the New York Stock Exchange (the "NYSE") notified the Company that the NYSE had determined to (a) commence proceedings to delist the Company's Class A common stock, par value $0.01 per share ("Common Stock") and (b) immediately suspend trading in the Company's Common Stock pursuant to Section 802.01D of the NYSE Listed Company Manual after the Company filed voluntary petitions for relief under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware on February 4, 2024.

8-K - Cano Health, Inc. (0001800682) (Filer)

Shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) rose sharply in today’s pre-market trading. 4DMT presented interim data from randomized Phase 2 PRISM clinical trial of intravitreal 4D-150 demonstrating favorable tolerability & clinical activity in wet AMD. 4D Molecular Therapeutics shares jumped 20.1% to $21.01 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Chenghe Acquisition Co. (NASDAQ:CHEA) gained 68.1% to $9.23 in pre-market trading after dipping around 46% on Friday. Tritium DCFC Limited (NASDAQ:DCFC) shares jumped 51.9% to $0.1990 in pre-market trading. Tritium DCFC said the company was the top-awarded fast charger manufacturer f

On Monday, value-based primary care provider Cano Health Inc (NASDAQ:CANO) entered into a Restructuring Support Agreement with lenders holding approximately 86% of its secured revolving and term loan debt and 92% of its senior unsecured notes.  This agreement enables Cano Health to reduce its debt. To facilitate this restructuring, Cano Health has initiated prearranged voluntary Chapter 11 proceedings in the U.S. Bankruptcy Court for the District of Delaware.  It has also received a commitment for $150 million in new debtor-in-possession financing from certain of its existing secured lenders, subject to Court approval.  This new capital is expected to provide sufficient liquidity to

Positions the Company to Advance Its Ongoing Transformation Plan Designed to Significantly Reduce Costs, Enhance Productivity, and Improve Cash Flow Receives Commitment for $150 Million in New Capital Ensures Patients Continue to Receive High-Quality Care Across Medical Centers MIAMI, Feb. 4, 2024 /PRNewswire/ -- Cano Health, Inc. (NYSE:CANO) ("Cano Health" or the "Company"), a leading value-based primary care provider and population health company, today announced that it has entered into a Restructuring Support Agreement (the "RSA") with lenders (the "Ad Hoc Lender Group") holding approximately 86% of its secured revolving and term loan debt and 92% of its senior unsecured notes. This a

4 - Cano Health, Inc. (0001800682) (Issuer)

4 - Cano Health, Inc. (0001800682) (Issuer)

SC 13G - Cano Health, Inc. (0001800682) (Subject)

SC 13D/A - Cano Health, Inc. (0001800682) (Subject)

4 - Cano Health, Inc. (0001800682) (Issuer)

4 - Cano Health, Inc. (0001800682) (Issuer)

Shares of KeyCorp (NYSE:KEY) moved lower during Thursday’s session after the company reported fourth-quarter financial results. Revenues of $1.538 billion, down 19.0% Y/Y, slightly topped the consensus of $1.532 billion. Adjusted EPS of 25 cents topped the street view of 23 cents. KeyCorp shares fell 5.4% to $13.10 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Lytus Technologies Holdings PTV. Ltd. (NASDAQ:LYT) shares jumped 92.8% to $0.1824 after falling 5% on Wednesday. Agrify Corporation (NASDAQ:AGFY) shares jumped 90% to $2.2401. Agrify said it entered into first Hydrocarbon Extraction Lab & Vertical Farming unit facility in California. Phunw

Gainers Celularity (NASDAQ:CELU) shares moved upwards by 44.7% to $0.27 during Thursday's regular session. The company's market cap stands at $52.8 million. NovoCure (NASDAQ:NVCR) shares increased by 24.15% to $15.42. The market value of their outstanding shares is at $1.6 billion. Jasper Therapeutics (NASDAQ:JSPR) shares moved upwards by 22.18% to $13.0. The market value of their outstanding shares is at $145.0 million. Nuvectis Pharma (NASDAQ:NVCT) shares moved upwards by 14.85% to $8.46. The company's market cap stands at $146.6 million. Bullfrog AI Hldgs (NASDAQ:BFRG) stock rose 14.74% to $3.66. The market value of their outstanding shares is at $22.3 million. Venus Concept (NASDAQ

Gainers Bullfrog AI Hldgs (NASDAQ:BFRG) stock increased by 26.1% to $3.33 during Wednesday's regular session. The company's market cap stands at $20.2 million. MAIA Biotechnology (AMEX:MAIA) shares rose 26.02% to $1.55. The company's market cap stands at $26.2 million. Kintara Therapeutics (NASDAQ:KTRA) stock moved upwards by 24.42% to $0.16. Anitra (AMEX:AZTR) shares moved upwards by 22.64% to $1.95. The market value of their outstanding shares is at $23.5 million. Evolus (NASDAQ:EOLS) shares rose 17.74% to $12.28. The market value of their outstanding shares is at $709.3 million. Jasper Therapeutics (NASDAQ:JSPR) stock increased by 16.42% to $10.42. The market value of their outstand

144 - Cano Health, Inc. (0001800682) (Subject)